ARCHIVES

Drugs and Targets: FDA extends Lymphoseek label to include mapping in solid tumors

This article is from The Cancer Letter archive.

Vol. 40 No. 41 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Progress Requires More Etiologists, D’Angio Says

September 15, 1978

In Brief: ACCC Celebrates 25th: James Hospital Receives Large Donations

April 9, 1999

In Brief: San Antonia Cancer Institute Designated Comprehensive; Yeast DNA Described

May 3, 1996

RFA On Promoters, Hormones, Other Cofactors Available

July 17, 1981

NCI’s Goal To Increase Minority Participation In Trials, Sondik Says

May 5, 1995

Radiotherapy In Combination With Zometa Provide Pain Control For Advanced Myeloma

February 27, 2004